The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent ...
JACKSON, WY / ACCESS Newswire / April 1, 2025 / Labor Smart, Inc. (OTC PINK:LTNC), through its newest subsidiary Elevate ...
GLP-1 users are upping their purchases of frozen fruits (44%) and vegetables (40%) while reducing impulse purchases and ...
A nurse has revealed exactly what you need to be drinking when you're on a GLP-1 medication - and why hydration on the ...
6h
HealthDay on MSNGLP-1 Drug Use For Weight Loss Has Soared, Costing BillionsKey Takeaways The number of people taking GLP-1 drugs to lose weight more than tripled in recent yearsThe percentage of ...
19h
MedPage Today on MSNGLP-1 Spending Hit $5.8 Billion in 2022 for U.S. Adults Without DiabetesThe prevalence of U.S. adults without diabetes who filled a GLP-1 receptor agonist prescription rose from 0.1% in 2018 to 0.4 ...
Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...
Full REMAIN-1 pivotal study enrollment anticipated in summer 2025 ...
In brief ... 💊 A new international clinical trial found that oral semaglutide reduces the risk of major cardiovascular ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.
Love Is Blind' alum Chelsea Blackwell shares her weight loss transformation after beginning the use of an injectable medication, despite facing criticism for doing so.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results